Suchita Vishwakarma

Suchita Vishwakarma is a PhD candidate in Pharmaceutical Sciences specializing in Medicinal Chemistry at the University of Cincinnati. Her research focuses on advancing small-molecule drug discovery and targeted protein degradation (TPD) through the development of novel E3 ligase platforms. Her doctoral work centers on FBXO21, an underexplored E3 ligase, and its application in developing next-generation PROTACs. With experience spanning structure-based drug design, organic synthesis, assay development, and early drug discovery, Suchita is interested in translating emerging technologies into impactful therapeutic solutions. She also has training in business, commercialization, and venture capital asset evaluation, with a particular interest in bridging scientific innovation, industry strategy, and therapeutic development.